6,6-DIMETHYL-5,6,7,8-TETRAHYDROQUINAZOLIN-4(3H)-ONE, 95.0%, 1g

Ulixertinib, 25mg

Ethyl 3-(4-bromophenyl)propanoate, 95.0%, 10g

4-BROMO-5-CHLORO-6-FLUORO-1H-INDAZOLE, 95%, 500mg

H-Asn(Trt)-OtBu, 97.0%, 5g

2-METHYL-2-(4-OXETAN-3-YL-PIPERAZIN-1-YL)-PROPIONALDEHYDE, 95.0%, 5g

Pyrimidine-2-carboxylic acid, 98.0%, 100g

1-(Benzo[d][1,3]dioxol-5-yl)-2,2,2-trifluoroethan-1-ol, 95+%, 500mg

Nitric acid, 10%, pure, 25 l, plastic packaging.

1-(Cyclopropylcarbonyl)-5-indolinesulfonyl chloride, 97%, 250mg

Triethylamine hydrobromide, 95.0%, 1g

4-Cyclohexylcyclohexanol (cis- and trans- mixture)>98.0%(GC)5g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-fluorophenyl)-2-methylpropanoic acid, 97%, 1g